0.0003
0.0000
(0.00%)
At close: January 9 at 7:00:00 PM EST
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-43,608.0000
-43,608.0000
-66,300.0000
-84,312.0000
Investing Cash Flow
-133.0000
-133.0000
7,853.0000
88,960.0000
Financing Cash Flow
9,655.0000
9,655.0000
10,668.0000
42,061.0000
End Cash Position
25,721.0000
25,721.0000
59,807.0000
107,586.0000
Capital Expenditure
-133.0000
-133.0000
-147.0000
-61.0000
Issuance of Capital Stock
9,639.0000
9,639.0000
10,664.0000
40,861.0000
Free Cash Flow
-43,741.0000
-43,741.0000
-66,447.0000
-84,373.0000
12/31/2020 - 10/2/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AVTE Aerovate Therapeutics, Inc.
2.5500
-3.41%
WBIO.CN WPD Pharmaceuticals Inc.
0.1900
0.00%
OBSEF ObsEva SA
0.0001
0.00%
HAVLF HAVN Life Sciences Inc.
0.0010
0.00%
SEOVF Sernova Corp.
0.1500
0.00%
AMPE Ampio Pharmaceuticals, Inc.
0.0026
0.00%
THRD Third Harmonic Bio, Inc.
8.35
-22.61%
NERV Minerva Neurosciences, Inc.
2.1750
-2.90%
ELTX Elicio Therapeutics, Inc.
6.13
+8.11%
ORGS Orgenesis Inc.
1.8000
0.00%